Published in ACS Nano on January 22, 2015
Fast Anion-Exchange in Highly Luminescent Nanocrystals of Cesium Lead Halide Perovskites (CsPbX3, X = Cl, Br, I). Nano Lett (2015) 1.22
Kinetics of the self-assembly of nanocrystal superlattices measured by real-time in situ X-ray scattering. Nat Mater (2016) 0.89
Brightness-equalized quantum dots. Nat Commun (2015) 0.83
Quasicrystalline nanocrystal superlattice with partial matching rules. Nat Mater (2016) 0.83
High-performance thermoelectric nanocomposites from nanocrystal building blocks. Nat Commun (2016) 0.81
Diverse Applications of Nanomedicine. ACS Nano (2017) 0.80
The Influence of Doping on the Optoelectronic Properties of PbS Colloidal Quantum Dot Solids. Sci Rep (2016) 0.79
Shape Control of Colloidal Cu2-x S Polyhedral Nanocrystals by Tuning the Nucleation Rates. Chem Mater (2016) 0.77
Identifying and Eliminating Emissive Sub-bandgap States in Thin Films of PbS Nanocrystals. Adv Mater (2015) 0.77
Nanosized Building Blocks for Customizing Novel Antibiofilm Approaches. J Dent Res (2016) 0.75
Nanocrystal solids: Order and progress. Nat Mater (2016) 0.75
Carbon wrapped hierarchical Li3V2(PO4)3 microspheres for high performance lithium ion batteries. Sci Rep (2016) 0.75
A Facile Methodology for Engineering the Morphology of CsPbX3 Perovskite Nanocrystals under Ambient Condition. Sci Rep (2016) 0.75
Host-guest chemistry for tuning colloidal solubility, self-organization and photoconductivity of inorganic-capped nanocrystals. Nat Commun (2015) 0.75
Crystal symmetry breaking and vacancies in colloidal lead chalcogenide quantum dots. Nat Mater (2016) 0.75
Electrically driven optical metamaterials. Nat Commun (2016) 0.75
Identifying short surface ligands on metal phosphide quantum dots. Phys Chem Chem Phys (2016) 0.75
Size-Dependent Melting Behavior of Colloidal In, Sn, and Bi Nanocrystals. Sci Rep (2015) 0.75
Dynamical Torque in CoxFe3-xO4 Nanocube Thin Films Characterized by Femtosecond Magneto-Optics: A π-Shift Control of the Magnetization Precession. Nano Lett (2016) 0.75
Face the Edges: Catalytic Active Sites of Nanomaterials. Adv Sci (Weinh) (2015) 0.75
Biological synthesis of fluorescent nanoparticles by cadmium and tellurite resistant Antarctic bacteria: exploring novel natural nanofactories. Microb Cell Fact (2016) 0.75
Electron-vibration coupling induced renormalization in the photoemission spectrum of diamondoids. Nat Commun (2016) 0.75
General low-temperature reaction pathway from precursors to monomers before nucleation of compound semiconductor nanocrystals. Nat Commun (2016) 0.75
Metal-Insulator Transition in Nanoparticle Solids: Insights from Kinetic Monte Carlo Simulations. Sci Rep (2017) 0.75
Single-crystal-to-single-crystal intercalation of a low-bandgap superatomic crystal. Nat Chem (2017) 0.75
Excited-State Dynamics in Colloidal Semiconductor Nanocrystals. Top Curr Chem (J) (2016) 0.75
Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet (2002) 16.56
Class of antiretroviral drugs and the risk of myocardial infarction. N Engl J Med (2007) 12.93
Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med (2003) 12.23
Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society-USA panel. JAMA (2008) 11.72
Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel. JAMA (2010) 9.26
Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med (2006) 9.21
Antiretroviral treatment of adult HIV infection: 2012 recommendations of the International Antiviral Society-USA panel. JAMA (2012) 8.94
Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. Lancet (2008) 8.73
Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater (2004) 6.19
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis (2008) 5.94
Cardiovascular disease risk factors in HIV patients--association with antiretroviral therapy. Results from the DAD study. AIDS (2003) 5.61
Incidence of Tuberculosis among HIV-infected patients receiving highly active antiretroviral therapy in Europe and North America. Clin Infect Dis (2005) 5.20
Prognosis of HIV-1-infected patients up to 5 years after initiation of HAART: collaborative analysis of prospective studies. AIDS (2007) 4.31
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study. Diabetes Care (2008) 4.10
Structural diversity in binary nanoparticle superlattices. Nature (2006) 4.01
Cytotoxicity of colloidal CdSe and CdSe/ZnS nanoparticles. Nano Lett (2005) 3.65
Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. Lancet (2004) 3.59
Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D Study. AIDS (2010) 3.47
Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study. J Infect Dis (2010) 3.30
CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. J Infect Dis (2013) 3.04
Biological applications of gold nanoparticles. Chem Soc Rev (2008) 3.01
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (2010) 2.98
"Giant" multishell CdSe nanocrystal quantum dots with suppressed blinking. J Am Chem Soc (2008) 2.96
Solution-processed PbS quantum dot infrared photodetectors and photovoltaics. Nat Mater (2005) 2.93
Science and technology roadmap for graphene, related two-dimensional crystals, and hybrid systems. Nanoscale (2015) 2.86
Estimated glomerular filtration rate, chronic kidney disease and antiretroviral drug use in HIV-positive patients. AIDS (2010) 2.85
Immunodeficiency at the start of combination antiretroviral therapy in low-, middle-, and high-income countries. J Acquir Immune Defic Syndr (2014) 2.79
Mortality and progression to AIDS after starting highly active antiretroviral therapy. AIDS (2003) 2.78
Predicting the risk of cardiovascular disease in HIV-infected patients: the data collection on adverse effects of anti-HIV drugs study. Eur J Cardiovasc Prev Rehabil (2010) 2.70
Two-photon luminescence imaging of cancer cells using molecularly targeted gold nanorods. Nano Lett (2007) 2.64
Serious fatal and nonfatal non-AIDS-defining illnesses in Europe. J Acquir Immune Defic Syndr (2010) 2.59
Tuberculosis after initiation of antiretroviral therapy in low-income and high-income countries. Clin Infect Dis (2007) 2.51
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE). PLoS Med (2013) 2.49
Multiple particle tracking in 3-D+t microscopy: method and application to the tracking of endocytosed quantum dots. IEEE Trans Image Process (2006) 2.48
Short statement of the first European Consensus Conference on the treatment of chronic hepatitis B and C in HIV co-infected patients. J Hepatol (2005) 2.45
PbSe nanocrystal solids for n- and p-channel thin film field-effect transistors. Science (2005) 2.30
HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies. AIDS (2008) 2.27
Multifunctional nanostructured materials for multimodal imaging, and simultaneous imaging and therapy. Chem Soc Rev (2008) 2.25
Multifunctional uniform nanoparticles composed of a magnetite nanocrystal core and a mesoporous silica shell for magnetic resonance and fluorescence imaging and for drug delivery. Angew Chem Int Ed Engl (2008) 2.21
Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl (2007) 2.19
Synthesis of monodisperse spherical nanocrystals. Angew Chem Int Ed Engl (2007) 2.12
Antibacterial properties of nanoparticles. Trends Biotechnol (2012) 2.11
Quasicrystalline order in self-assembled binary nanoparticle superlattices. Nature (2009) 2.08
Chronic renal failure among HIV-1-infected patients. AIDS (2007) 2.07
Depleted-heterojunction colloidal quantum dot solar cells. ACS Nano (2010) 2.05
Synthesis and micrometer-scale assembly of colloidal CdSe/CdS nanorods prepared by a seeded growth approach. Nano Lett (2007) 2.03
Synthesis of CulnS2, CulnSe2, and Cu(InxGa(1-x))Se2 (CIGS) nanocrystal "inks" for printable photovoltaics. J Am Chem Soc (2008) 1.99
Two types of luminescence blinking revealed by spectroelectrochemistry of single quantum dots. Nature (2011) 1.98
The changing incidence of AIDS events in patients receiving highly active antiretroviral therapy. Arch Intern Med (2005) 1.97
Continuous antiretroviral therapy decreases bone mineral density. AIDS (2009) 1.96
Tunable near-infrared and visible-light transmittance in nanocrystal-in-glass composites. Nature (2013) 1.94
Stoichiometric control of lead chalcogenide nanocrystal solids to enhance their electronic and optoelectronic device performance. ACS Nano (2013) 1.92
Risk factors for treatment-limiting toxicities in patients starting nevirapine-containing antiretroviral therapy. AIDS (2009) 1.90
Nevirapine and efavirenz elicit different changes in lipid profiles in antiretroviral-therapy-naive patients infected with HIV-1. PLoS Med (2004) 1.89
Non-blinking and photostable upconverted luminescence from single lanthanide-doped nanocrystals. Proc Natl Acad Sci U S A (2009) 1.88
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Clin Infect Dis (2009) 1.86
A quantitative fluorescence study of protein monolayer formation on colloidal nanoparticles. Nat Nanotechnol (2009) 1.85
Prognostic importance of anaemia in HIV type-1-infected patients starting antiretroviral therapy: collaborative analysis of prospective cohort studies. Antivir Ther (2008) 1.83
Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection. Biomaterials (2010) 1.77
Biological applications of magnetic nanoparticles. Chem Soc Rev (2012) 1.76
Controlled growth of tetrapod-branched inorganic nanocrystals. Nat Mater (2003) 1.76
Colloidal nanocrystal heterostructures with linear and branched topology. Nature (2004) 1.75
Dissecting the molecular mechanism of apoptosis during photothermal therapy using gold nanoprisms. ACS Nano (2014) 1.75
Ritonavir impairs lipoprotein lipase-mediated lipolysis and decreases uptake of fatty acids in adipose tissue. Arterioscler Thromb Vasc Biol (2005) 1.75
HIV-1 infection and cognitive impairment in the cART era: a review. AIDS (2011) 1.72
Binary nanocrystal superlattice membranes self-assembled at the liquid-air interface. Nature (2010) 1.70
Safe interruption of maintenance therapy against previous infection with four common HIV-associated opportunistic pathogens during potent antiretroviral therapy. Ann Intern Med (2002) 1.70
Galvanic replacement reactions in metal oxide nanocrystals. Science (2013) 1.69
Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Med (2014) 1.69
Band-like transport, high electron mobility and high photoconductivity in all-inorganic nanocrystal arrays. Nat Nanotechnol (2011) 1.66
An internationally generalizable risk index for mortality after one year of antiretroviral therapy. AIDS (2013) 1.64
Semiconductor quantum rods as single molecule fluorescent biological labels. Nano Lett (2007) 1.63
Fabrication of hollow palladium spheres and their successful application to the recyclable heterogeneous catalyst for suzuki coupling reactions. J Am Chem Soc (2002) 1.63
Colloidal nanocrystals with molecular metal chalcogenide surface ligands. Science (2009) 1.61
The influence of efavirenz on the pharmacokinetics of a twice-daily combination of indinavir and low-dose ritonavir in healthy volunteers. Clin Pharmacol Ther (2002) 1.61
The restoration potential of the Mesopotamian marshes of Iraq. Science (2005) 1.60
The Coding Causes of Death in HIV (CoDe) Project: initial results and evaluation of methodology. Epidemiology (2011) 1.59
Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis (2014) 1.59
Uniform mesoporous dye-doped silica nanoparticles decorated with multiple magnetite nanocrystals for simultaneous enhanced magnetic resonance imaging, fluorescence imaging, and drug delivery. J Am Chem Soc (2010) 1.58
Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr (2011) 1.58
Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev (2011) 1.57
Factors affecting transmission of mucosal human papillomavirus. Lancet Infect Dis (2010) 1.56
Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. Nano Lett (2007) 1.56
Is it safe to discontinue primary Pneumocystis jiroveci pneumonia prophylaxis in patients with virologically suppressed HIV infection and a CD4 cell count <200 cells/microL? Clin Infect Dis (2010) 1.54
Effects of antiretroviral therapy on semen quality. AIDS (2008) 1.54
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE. PLoS Med (2012) 1.54
Designed fabrication of multifunctional magnetic gold nanoshells and their application to magnetic resonance imaging and photothermal therapy. Angew Chem Int Ed Engl (2006) 1.54
Size-dependent intrinsic radiative decay rates of silicon nanocrystals at large confinement energies. Phys Rev Lett (2008) 1.53
The role of metal nanoparticles in remote release of encapsulated materials. Nano Lett (2005) 1.53
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV? AIDS (2005) 1.52
Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia. AIDS (2006) 1.52
Magnetic fluorescent delivery vehicle using uniform mesoporous silica spheres embedded with monodisperse magnetic and semiconductor nanocrystals. J Am Chem Soc (2006) 1.51
Fast, sensitive and spectrally tuneable colloidal-quantum-dot photodetectors. Nat Nanotechnol (2008) 1.50